3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Glioblastoma
2
Thrombocythemia, Essential
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Renal Insufficiency
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pathologic Complete Response
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Melanoma
1
Lung Neoplasms
1
Liver Failure
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Glioma
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Transitional Cell
1
Interventions
Cyclophosphamide
12
Vincristine
9
Etoposide
8
venetoclax
6
Methotrexate
6
Doxorubicin
6
Dexamethasone
6
Cytarabine
6
Prednisone
5
Calcium Dobesilate
5
prednylidene
4
pegaspargase
4
merphos
4
dexamethasone acetate
4
dexamethasone 21-phosphate
4
deltacortene
4
calaspargase pegol
4
auricularum
4
Specimen Handling
4
Granulocyte Colony-Stimulating Factor
4
fludarabine phosphate
3
daratumumab
3
Thioguanine
3
Rituximab
3
Peripheral Blood Stem Cell Transplantation
3
Mercaptopurine
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Hydrocortisone
3
Filgrastim
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
veliparib
×
90 days
×
Clear all
No trials found.